Who is sponsoring NCT05210738?

NCT05210738 is sponsored by The Christ Hospital.

What drugs are being tested in NCT05210738?

Interventions in NCT05210738: Single incision sling, Bulkamid bulking agent.

What condition does NCT05210738 study?

NCT05210738 studies Stress Incontinence, Female.

Is NCT05210738 still recruiting?

NCT05210738 is currently completed. Last updated 27 January 2022.

Last reviewed 2022-01-27 · How we verify

NCT05210738

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single-incision Sling vs Urethral Bulking During Prolapse Surgery for Occult Stress Incontinence

Completed Last updated 27 January 2022

What this trial tests

trial testing Single incision sling in Stress Incontinence, Female in 60 participants. Completed in 1 June 2021.

Timeline

1 January 2019

Primary endpoint
1 June 2021

1 June 2021

Quick facts

Lead sponsor	The Christ Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 January 2019
Primary completion	1 June 2021
Estimated completion	1 June 2021
Sites	1 location across United States

Drugs / interventions tested

Single incision sling
Bulkamid bulking agent — full drug profile →

Conditions studied

Stress Incontinence, Female — all drugs for Stress Incontinence, Female →

Sponsor

The Christ Hospital

Who can join

Adults 18 to 85, female only, with Stress Incontinence, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to compare outcomes of two different procedures to prevent occult stress urinary incontinence (SUI) in patients who are having pelvic organ prolapse surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stress Incontinence, Female

Currently open trials in the same condition.

NCT06885463 — PRP & PDO Threads in Treatment of Stress Incontinence · NA · recruiting

Other The Christ Hospital trials

Trials by the same sponsor.

NCT04513600 — ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy · unknown
NCT04355897 — CoVID-19 Plasma in Treatment of COVID-19 Patients · EARLY_PHASE1 · completed
NCT03923348 — Pelvic Floor Muscle Training With Leva System for Urge Incontinence · NA · terminated
NCT03633994 — Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy · Phase 2 · unknown
NCT03570112 — Transmission of Chronic Hepatitis C in Pregnancy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05210738 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Christ Hospital
Last refreshed: 27 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05210738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing